The Bacteria Didn’t Break Your Gut. Your Cells Did. Here’s What That Actually Means.

I want to take a few minutes and explain something I’ve been building quietly for years — because I think it’s time more people understood it.

It’s called the Host Capacity Model. And it’s not a protocol. It’s not a supplement stack. It’s not a lab panel with a clever name.

It’s a complete reframe of why chronic gut dysfunction, mast cell activation, and the conditions that cluster around them actually exist — and why so many people keep failing to get better despite doing everything right.

The Problem With How We Currently Think About This

The dominant model — in functional medicine, integrative practice, even the more sophisticated corners of the gut health world — goes something like this:

Something disrupted your microbiome. The wrong bacteria moved in. We need to identify them and remove them. Then we restore balance.

It sounds logical. It’s built on real science. And it fails people every single day.

I know this because I’ve spent years going far deeper than the clinical surface — into bacterial biology itself. How these organisms are built. How they sense their environment. How they regulate their own survival, their metabolism, their behavior under stress.

And what you find, when you actually study the microbial world at that level, is something that changes the entire picture:

Bacteria are not invaders making independent decisions. They are ecological responders.

They do what their environment tells them to do. They thrive, shift, overgrow, or collapse based on the conditions the host creates — not the other way around.

Which means if your environment is wrong, you can eliminate every “bad” organism and they will come back. Or something else will fill the space. Because the conditions that selected for them in the first place haven’t changed.

This is where the Host Capacity Model begins.

What the Model Actually Says

The central thesis is this:

Chronic gut dysfunction — and the cascade of conditions that follow from it — is not a microbial disease. It is a host metabolic-epigenetic failure. And the primary site of that failure is the colonocyte.

The colonocyte is the cell lining the inner wall of your colon. It is one of the most metabolically demanding cells in the human body. It relies almost exclusively on a molecule called butyrate — produced by your gut bacteria — as its primary fuel source. It uses that fuel to power its mitochondria, maintain the gut barrier, regulate immune signaling, and keep the entire local ecosystem in order.

When the colonocyte’s mitochondria begin to fail — when they can no longer efficiently oxidize butyrate, when their energy output drops, when oxidative stress accumulates inside the cell — everything downstream begins to collapse.

And I mean everything.

The gut barrier weakens. The tight junctions between cells lose their integrity. Bacterial products — lipopolysaccharides, flagellin, metabolic byproducts — begin crossing into the bloodstream. This is not “leaky gut” as a vague concept. It is a specific, mechanistic consequence of colonocyte bioenergetic failure.

The microbial ecology shifts. When butyrate-producing bacteria can no longer sustain their populations — because the host environment no longer supports them — other organisms move in. Hydrogen sulfide producers. Methanogens. Organisms adapted to low-oxygen, inflammatory, energetically depleted environments. The microbiome doesn’t cause the dysfunction. It reflects it.

Immune regulation breaks down. The gut is home to the largest concentration of immune tissue in the body. When the colonocyte fails, the signals that normally keep immune activity calibrated begin to distort. Mast cells — which sit at the interface between the gut, the immune system, and the nervous system — become dysregulated. They begin activating on signals they shouldn’t. They release mediators that drive inflammation, histamine responses, neurological symptoms, and systemic hypersensitivity.

This is where MCAS enters the picture. Mast cell activation syndrome, in the Host Capacity Model, is not a primary disease. It is a downstream expression of a system that has lost its regulatory capacity — a system whose metabolic and epigenetic gating mechanisms have been overwhelmed.

Epigenetic regulation fails. This is the layer most models miss entirely. The genes that control how your immune cells behave, how your gut cells respond to signals, how inflammation is turned on and off — these are regulated epigenetically. Enzymes like DNMT3A and TET2 control DNA methylation patterns. Histone modifications gate which genes are expressed and when. All of this is metabolically powered. When the bioenergetics collapse, the epigenetic layer destabilizes. Gene expression patterns shift in ways that perpetuate dysfunction even when other variables improve. This is why some people never fully recover — their regulatory architecture has been rewritten at a level most interventions don’t reach.

Neuroinflammation follows. The gut-brain axis is not a metaphor. It is a physical, bidirectional communication network — through the vagus nerve, through circulating immune mediators, through the kynurenine pathway, through mast cell-microglia crosstalk at the blood-brain barrier. When the gut environment deteriorates far enough, the brain begins to show it. Cognitive symptoms. Dysautonomia. Nervous system hypersensitivity. Conditions like POTS that seem entirely unrelated to the gut but trace back, mechanistically, to the same root failure.

How I Work With Clients

When someone comes to me, I am not asking what bacteria do you have or which foods are you reacting to.

I am asking: where in this cascade did the system begin to fail, and what is still holding it in place?

I do a deep, structured analysis of the client’s full history — symptoms, timeline, prior interventions, labs, and the pattern of what has and hasn’t worked. I am looking for the mechanistic fingerprint of where host capacity broke down.

I look at mitochondrial function indicators. I look at inflammatory load and its distribution. I look at oxidative stress markers. I look at immune activation patterns — specifically mast cell behavior. I look at how the nervous system is expressing the dysfunction. I look at epigenetic risk factors and how they interact with the metabolic picture.

Then I map the client’s presentation onto the model — identifying which failure points are primary, which are secondary, and what the hierarchy of dysfunction actually looks like in their specific case.

This is not a one-size protocol. It is not a template. Every client I work with presents a different configuration of the same underlying architecture — and the work is in reading that configuration accurately.

I work with people who have chronic gut dysfunction that hasn’t responded to standard approaches. People with SIBO that keeps coming back. People with mast cell activation syndrome who have been told to just avoid their triggers. People with complex, multi-system presentations where no single diagnosis has been able to hold the whole picture.

What I offer is a framework that can hold the whole picture — because it starts at the level where the whole picture originates.

If this is where you are — if you’ve been through the protocols and the diets and the antimicrobials and the elimination plans and you’re still not better — I want you to know that there is a deeper explanation available.

And it starts with asking the right question.

📩 research@biomelogic.net

If this post reached you at the right moment, please share it. Someone in your life may need to read this more than you know.

Thank you — genuinely — for being here and for following this work as it develops. This model has been years in the making, and your presence as witness to it means more than I can say.

#HostCapacityModel #Biomelogic #ChronicGutDysfunction #MastCellActivation #MCAS #SIBO #MitochondrialHealth #Neuroinflammation #EpigeneticHealth #GutBrainAxis #POTS #Dysautonomia #FunctionalMedicine #IntegrativeMedicine #ChronicIllness